Diacylglycerol kinases are essential for hepatocyte growth factor-dependent proliferation and motility of Kaposi's sarcoma cells

Cancer Science

Volumn 102, Issue 7, 2011, Pages 1329-1336

  Baldanzi, Gianluca ^a   Pietronave, Stefano ^a,c   Locarno, Deborah ^a   Merlin, Simone ^a   Porporato, Paolo ^a   Chianale, Federica ^a   Filigheddu, Nicoletta ^a   Cantelmo, Anna Rita ^b   Albini, Adriana ^b   Graziani, Andrea ^a   Prat, Maria ^a  

^a UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^b IRCCS MULTIMEDICA   (Italy)

^c TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

3 [2 [4 (4,4' DIFLUOROBENZHYDRYLIDENE)PIPERIDINO]ETHYL] 2,3 DIHYDRO 2 THIOXO 4(1H) QUINAZOLINONE; DIACYLGLYCEROL KINASE; SCATTER FACTOR; SMALL INTERFERING RNA;

ARTICLE; CARCINOGENESIS; CELL ADHESION; CELL MOTILITY; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; DRUG TARGETING; HUMAN; HUMAN CELL; KAPOSI SARCOMA; PRIORITY JOURNAL;

CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; DIACYLGLYCEROL KINASE; HEPATOCYTE GROWTH FACTOR; HUMANS; PIPERIDINES; PROTO-ONCOGENE PROTEINS C-MET; QUINAZOLINONES; SARCOMA, KAPOSI; SIGNAL TRANSDUCTION;

EID: 79959200971     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2011.01953.x     Document Type: Article

References (49)

1. Gill PS, Hamilton A, Naidu Y. Epidemic (AIDS-related) Kaposi's sarcoma: epidemiology, pathogenesis, and treatment. AIDS 1994; 7: 1.
2. Ensoli B, Sturzl M. Kaposi's Sarcoma: a result of the interplay among inflammatory cytokines, angiogenic factors and viral agents. Cytokine Growth Factor Rev 1998; 9: 63-83.
3. Reitz MS, Nerurkar LS, Gallo RC. Perspective on Kaposi's Sarcoma: facts, concepts, and conjectures. J Natl Cancer Inst 1999; 91: 1453-8.
4. Viejo-Borbolla A, Schulz TF. Kaposi's sarcoma-associated herpesvirus (KSHV/HHV8): key aspects of epidemiology and pathogenesis. AIDS Rev 2003; 5: 222-9.
5. Aoki Y, Tosato G. Interactions between HIV-1 Tat and KSHV. Curr Top Microbiol Immunol 2007; 312: 309-26.
6. Sodhi S, Montaner V, Patel M et al. The Kaposi's Sarcoma-associated herpes virus G protein-coupled receptor up-regulates vascular endothelial growth factor expression and secretion through mitogen-activated protein kinase and p38 pathways acting on hypoxia-inducible factor 1alpha. Cancer Res 2000; 60: 4873-80.
7. Gasperini P, Sakakibara S, Tosato G. Contribution of viral and cellular cytokines to Kaposi's sarcoma-associated herpesvirus pathogenesis. J Leukoc Biol 2008; 84: 994-1000.
8. Polverini PJ, Nickoloff BJ. Role of scatter factor and the c-met protooncogene in the pathogenesis of AIDS-associated Kaposi's Sarcoma. Adv Cancer Res 1995; 66: 235-53.
9. Maier JA, Mariotti M, Albini A et al. Over-expression of hepatocyte growth factor in human Kaposi's Sarcoma. Int J Cancer 1996; 65: 168-72.
10. Montaldo F, Maffe A, Morini M et al. Expression of functional tyrosine kinases on immortalized Kaposi's Sarcoma cells. J Cell Physiol 2000; 184: 246-54.
11. Naidu YM, Rosen EM, Zitnick R et al. Role of scatter factor in the pathogenesis of AIDS-related Kaposi Sarcoma. Proc Natl Acad Sci USA 1994; 91: 5281-5.
12. Bussolino F, Di Renzo MF, Ziche M et al. Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth. J Cell Biol 1992; 119: 629-41.
13. Birchmeier A, Birchmeier W, Gherardi E, Vande Woude GF. Developmental roles of HGF/SF and its receptor, the c-Met tyrosine kinase. Nat Rev Mol Cell Biol 2003; 4: 915-25.
14. Bardelli C, Sala M, Cavallazzi U, Prat M. Agonist Met antibodies define the signalling threshold required for a full mitogenic and invasive program of Kaposi's Sarcoma cells. Biochem Biophys Res Commun 2005; 334: 1172-9.
15. Sullivan R, Dezube BJ, Koon HB. Signal transduction targets in Kaposi's sarcoma. Curr Opin Oncol 2006; 18: 456-62.
16. Lambert PJ, Shahrier AZ, Whitman AG et al. Targeting the PI3K and MAPK pathways to treat Kaposi's-sarcoma-associated herpes virus infection and pathogenesis. Expert Opin Ther Targets 2007; 11: 589-99.
17. Carrasco S, Mérida I. Diacylglycerol, when simplicity becomes complex. Trends Biochem Sci 2007; 32: 27-36.
18. Sakane F, Imai S, Kai M, Yasuda S, Kanoh H. Diacylglycerol kinases: why so many of them?. Biochim Biophys Acta 2007; 1771: 793-806.
19. Topham MK, Prescott SM. Mammalian diacylglycerol kinases, a family of lipid kinases with signaling functions. J Biol Chem 1999; 274: 11447-50.
20. Cutrupi S, Baldanzi G, Gramaglia D et al. Src-mediated activation of alpha-diacylglycerol kinase is required for hepatocyte growth factor-induced cell motility. EMBO J 2000; 19: 4614-22.
21. Baldanzi G, Mitola S, Cutrupi S et al. Activation of diacylglycerol kinase alpha is required for VEGF-induced angiogenic signaling in vitro. Oncogene 2004; 23: 4828-38.
22. Davidson L, Pawson AJ, López de Maturana R et al. Gonadotropin-releasing hormone-induced activation of diacylglycerol kinase-zeta and its association with active c-src. J Biol Chem 2004; 279: 11906-16.
23. Tabellini G, Billi AM, Falà F et al. Nuclear diacylglycerol kinase-theta is activated in response to nerve growth factor stimulation of PC12 cells. Cell Signal 2004; 16: 1263-71.
24. Nelson CD, Perry SJ, Regier DS, Prescott SM, Topham MK, Lefkowitz RJ. Targeting of diacylglycerol degradation to M1 muscarinic receptors by beta-arrestins. Science 2007; 315: 663-6.
25. Chianale F, Cutrupi S, Rainero E et al. Diacylglycerol kinase-alpha mediates hepatocyte growth factor-induced epithelial cell scatter by regulating Rac activation and membrane ruffling. Mol Biol Cell 2007; 18: 4859-71.
26. Bacchiocchi R, Baldanzi G, Carbonari D et al. Activation of alpha-diacylglycerol kinase is critical for the mitogenic properties of anaplastic lymphoma kinase. Blood 2005; 106: 2175-82.
27. Regier DS, Higbee J, Lund KM, Sakane F, Prescott SM, Topham MK. Diacylglycerol kinase iota regulates Ras guanyl-releasing protein 3 and inhibits Rap1 signaling. Proc Natl Acad Sci USA 2005; 102: 7595-600.
28. Jiang Y, Sakane F, Kanoh H, Walsh JP. Selectivity of the diacylglycerol kinase inhibitor 3-[2-(4-[bis-(4-fluorophenyl)methylene]-1-piperidinyl)ethyl]-2, 3-dihydro-2-thioxo-4(1H) quinazolinone (R59949) among diacylglycerol kinase subtypes. Biochem Pharmacol 2000; 59: 763-72.
29. Prat M, Crepaldi T, Gandino L, Giordano S, Longati P, Comoglio P. C-terminal truncated forms of Met, the hepatocyte growth factor receptor. Mol Cell Biol 1991; 11: 5954-62.
30. Prat M, Crepaldi T, Pennacchietti S, Bussolino F, Comoglio PM. Agonistic monoclonal antibodies against the Met receptor dissect the biological responses to HGF. J Cell Sci 1998; 111: 237-47.
31. Siegal B, Levinton-Kriss S, Schiffer A et al. Kaposi's sarcoma in immunosuppression. Possibly the result of a dual viral infection. Cancer 1990; 65: 492-8.
32. de Chaffoy de Courcelles D, Roevens P, Van Belle H, Kennis L, Somers Y, De Clerck F. The role of endogenously formed diacylglycerol in the propagation and termination of platelet activation. A biochemical and functional analysis using the novel diacylglycerol kinase inhibitor, R 59 949. J Biol Chem 1989; 264: 3274-85.
33. Benelli R, Albini A. In vitro models of angiogenesis: the use of Matrigel. Int J Biol Markers 1999; 14: 243-6.
34. Herndier BG, Werner A, Arnstein P et al. Characterization of a human Kaposi's sarcoma cell line that induces angiogenic tumors in animals. AIDS 1994; 8: 575-81.
35. Prakash O, Tang ZY, He YE et al. Human Kaposi's sarcoma cell-mediated tumorigenesis in human immunodeficiency type 1 tat-expressing transgenic mice. J Natl Cancer Inst 2000; 92: 721-8.
36. Sharma GD, He J, Bazan HE. p38 and ERK1/2 coordinate cellular migration and proliferation in epithelial wound healing: evidence of cross-talk activation between MAP kinase cascades. J Biol Chem 2003; 278: 21989-97.
37. Scarpino S, Stoppacciaro A, Ballerini F et al. Papillary carcinoma of the thyroid: hepatocyte growth factor (HGF) stimulates tumor cells to release chemokines active in recruiting dendritic cells. Am J Pathol 2000; 156: 831-7.
38. Zhang YW, Su Y, Volpert OV, Vande Woude GF. Hepatocyte growth factor/scatter factor mediates angiogenesis through positive VEGF and negative thrombospondin 1 regulation. Proc Natl Acad Sci USA 2003; 100: 12718-23.
39. Miele C, Paturzo F, Teperino R et al. Glucose regulates diacylglycerol intracellular levels and protein kinase C activity by modulating diacylglycerol kinase subcellular localization. J Biol Chem 2007; 282: 31835-43.
40. Tang W, Bunting M, Zimmerman GA, McIntyre TM, Prescott SM. Molecular cloning of a novel human diacylglycerol kinase highly selective for arachidonate-containing substrates. J Biol Chem 1996; 271: 10237-41.
41. Baldanzi G, Alchera E, Imarisio C et al. Negative regulation of diacylglycerol kinase theta mediates adenosine-dependent hepatocyte preconditioning. Cell Death Differ 2010; 17: 1059-68.
42. Bunting M, Tang W, Zimmerman GA, McIntyre TM, Prescott SM. Molecular cloning and characterization of a novel human diacylglycerol kinase zeta. J Biol Chem 1996; 271: 10230-6.
43. Filigheddu N, Cutrupi S, Porporato PE et al. Diacylglycerol kinase is required for HGF-induced invasiveness and anchorage-independent growth of MDA-MB-231 breast cancer cells. Anticancer Res 2007; 27: 1489-92.
44. Abramovici H, Gee SH. Morphological changes and spatial regulation of diacylglycerol kinase-zeta, syntrophins, and Rac1 during myoblast fusion. Cell Motil Cytoskeleton 2007; 64: 549-67.
45. Raben DM, Tu-Sekine B. Nuclear diacylglycerol kinases: regulation and roles. Front Biosci 2008; 13: 590-7.
46. Kai M, Yasuda S, Imai S, Toyota M, Kanoh H, Sakane F. Diacylglycerol kinase alpha enhances protein kinase Czeta-dependent phosphorylation at Ser311 of p65/RelA subunit of nuclear factor-kappaB. FEBS Lett 2009; 583: 3265-8.
47. Li D, Urs NA, Allegood J, Leon A, Merrill AH, Sewer MB. Cyclic AMP-stimulated interaction between steroidogenic factor 1 and diacylglycerol kinase facilitates induction of CYP17. Mol Cell Biol 2007; 19: 6669-85.
48. Crotty T, Cai J, Sakane F, Taketomi A, Prescott SM, Topham MK. Diacylglycerol kinase delta regulates protein kinase C and epidermal growth factor receptor signaling. Proc Natl Acad Sci USA 2006; 103: 15485-90.
49. Flores I, Casaseca T, Martinez-A C, Kanoh H, Merida I. Phosphatidic acid generation through interleukin 2 (IL-2)-induced alpha-diacylglycerol kinase activation is an essential step in IL-2-mediated lymphocyte proliferation. J Biol Chem 1996; 271: 10334-40.